C12N2310/3515 - page 4 - CPC Classification Index

#901

20130259908

2013-10-03

Micro-RNA family that modulates fibrosis and uses thereof

#902

20130210891

2013-08-15

Pharmaceutical composition for transcolonic absorption

#903

20130197055

2013-08-01

Inhibition of PCSK9 through RNAi

#904

20130195891

2013-08-01

Micro-RNA family that modulates fibrosis and uses thereof

#905

20130184329

2013-07-18

Compositions and methods for inhibiting expression of mutant EGFR gene

#906

20130165496

2013-06-27

Compounds and methods for modulating expression of DGAT2

#907

20130131141

2013-05-23

Reduced size self-delivering RNAi compounds

#908

20130121988

2013-05-16

Nucleic acid comprising GXGas an immune-stimulating agent/adjuvant

#909

20130116307

2013-05-09

Cyclic cationic lipids and methods of use

#910

20130072854

2013-03-21

MICROBUBBLE COMPLEXES AND METHODS OF USE

#911

20130065950

2013-03-14

Modified oligonucleotides for telomerase inhibition

#912

20130065943

2013-03-14

Compositions and methods for inhibiting expression of CD45 gene

#913

20130052176

2013-02-28

Aptamer for NGF and use thereof

#914

20130039895

2013-02-14

miR-150 for the treatment of blood disorders

#915

20130035371

2013-02-07

Lipid formulated dsRNA targeting the PCSK9 gene

#916

20130035369

2013-02-07

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#917

20130034599

2013-02-07

SYNTHETIC NANOSTRUCTURES INCLUDING NUCLEIC ACIDS AND/OR OTHER ENTITIES

#918

20130023577

2013-01-24

Compositions and methods for inhibiting expression of Eg5 and VEGF genes

#919

20130018085

2013-01-17

iRNA Agents Targeting VEGF

#920

20130018084

2013-01-17

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

#921

20130012571

2013-01-10

Organic compositions to treat Beta-ENaC-related diseases

#922

20130012570

2013-01-10

GNAQ targeted dsRNA compositions and methods for inhibiting expression

#923

20120329858

2012-12-27

MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION

#924

20120328694

2012-12-27

THERAPEUTIC AGENT FOR FIBROID LUNG

#925

20120322991

2012-12-20

Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types

#926

20120322855

2012-12-20

Duplex oligonucleotide complexes and methods for gene silencing by RNA interference

#927

20120315288

2012-12-13

Low density lipoprotein receptor-mediated siRNA delivery

#928

20120283319

2012-11-08

Method of inhibiting miR-33 using a modified oligonucleotide

#929

20120259001

2012-10-11

Duplex oligonucleotides with enhanced functionality in gene regulation

#930

20120258144

2012-10-11

Suppressors of CpG oligonucleotides and methods of use

#931

20120252872

2012-10-04

RNAi modulation of APOB and uses thereof

#932

20120245076

2012-09-27

COMPOSITIONS AND METHODS FOR DELIVERING RNAI USING APOE

#933

20120238618

2012-09-20

Antisense oligonucleotides for inhibition of microRNA-21

#934

20120225927

2012-09-06

Compositions and methods for inhibiting expression of transthyretin

#935

20120214861

2012-08-23

METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE

#936

20120208864

2012-08-16

COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF GCGR

#937

20120208860

2012-08-16

Compositions and methods for inhibiting expression of factor VII gene

#938

20120207744

2012-08-16

REPROGRAMMING COMPOSITIONS AND METHODS OF USING THE SAME

#939

20120201872

2012-08-09

Liposomes comprising a calcium phosphate-containing precipitate

#940

20120190580

2012-07-26

TREATMENT OF PATIENTS AFTER STENT IMPLANTATION OR BALLOON DILATATION AND DRUG ELUTING STENTS

#941

20120184595

2012-07-19

Compositions and methods for silencing apolipoprotein C-III expression

#942

20120183602

2012-07-19

Lipid formulation

#943

20120180147

2012-07-12

MicroRNA-24

#944

20120177723

2012-07-12

siRNA phospholipid conjugate

#945

20120165397

2012-06-28

Chemical modification of short small hairpin RNAs for inhibition of gene expression

#946

20120165393

2012-06-28

Peptide-based in vivo siRNA delivery system

#947

20120157514

2012-06-21

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#948

20120142765

2012-06-07

Sphingosine-bound siRNA

#949

20120142757

2012-06-07

RNAi Modulation of AHA and Therapeutic Uses Thereof

#950

20120136145

2012-05-31

Compositions and Methods for Inhibiting Expression of Eg5 Gene

#951

20120129918

2012-05-24

MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION

#952

20120129913

2012-05-24

dsRNA for treating viral infection

#953

20120128761

2012-05-24

Lipophilic polynucleotide conjugates

#954

20120122962

2012-05-17

Modified Small Interfering RNA Molecules and Methods of Use

#955

20120122960

2012-05-17

Organic compositions to treat Beta-ENaC-related diseases

#956

20120122959

2012-05-17

Targeting MicroRNAs for metabolic disorders

#957

20120122216

2012-05-17

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#958

20120115934

2012-05-10

Organic compositions to treat beta-ENaC-related diseases

#959

20120115933

2012-05-10

Organic compositions to treat Beta-ENaC-related diseases

#960

20120108803

2012-05-03

siRNA conjugate and preparation method thereof

#961

20120095076

2012-04-19

Compositions and methods for inhibiting expression of huntingtin gene

#962

20120095075

2012-04-19

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

#963

20120087949

2012-04-12

OLIGONUCLEOTIDE MICELLES

#964

20120083596

2012-04-05

Pharmaceutical Composition

#965

20120065243

2012-03-15

RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality

#966

20120045395

2012-02-23

MicroRNAs In Idiopathic Pulmonary Fibrosis

#967

20120040459

2012-02-16

Reduced size self-delivering RNAi compounds

#968

20120035248

2012-02-09

Method for inhibiting the activity of mir-155

#969

20120035115

2012-02-09

Chemical modifications of monomers and oligonucleotides with cycloaddition

#970

20120027796

2012-02-02

Lipids and compositions for the delivery of therapeutics

#971

20120022132

2012-01-26

Compositions and methods for inhibiting expression of mutant EGFR gene

#972

20120022002

2012-01-26

Sustained release siRNA for ocular drug delivery

#973

20120016009

2012-01-19

Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene

#974

20120016006

2012-01-19

Compositions And Methods For Increasing Cellular Uptake Of RNAi Via SID-1

#975

20120004280

2012-01-05

RNA interference mediated inhibition of the FCεR1α gene

#976

20110311583

2011-12-22

Lipids and compositions for the delivery of therapeutics

#977

20110311582

2011-12-22

Lipids and compositions for the delivery of therapeutics

#978

20110294692

2011-12-01

USE OF MIR-126 FOR ENHANCING HEMATOPOIETIC STEM CELL ENGRAFTMENT, FOR ISOLATING HEMATOPOIETIC STEM CELLS, AND FOR TREATING AND MONITORING THE TREATMENT OF ACUTE MYELOID LEUKEMIA

#979

20110293703

2011-12-01

Aminoalcohol lipidoids and uses thereof

#980

20110263684

2011-10-27

Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene

#981

20110263681

2011-10-27

Organic compositions to treat beta-ENaC-related diseases

#982

20110263680

2011-10-27

Reduced size self-delivering RNAi compounds

#983

20110263514

2011-10-27

Delivery of agents using interfering nanoparticles

#984

20110251261

2011-10-13

Compositions and methods for inhibition of nucleic acids function

#985

20110251257

2011-10-13

METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE

#986

20110244025

2011-10-06

MODIFIED OLIGORIBONUCLEOTIDE ANALOGS WITH ENHANCED IMMUNOSTIMULATORY ACTIVITY

#987

20110237648

2011-09-29

RNA interference in skin indications

#988

20110237522

2011-09-29

Neutral nanotransporters

#989

20110237435

2011-09-29

Lipophilic nucleic acid delivery vehicle and methods of use thereof

#990

20110230546

2011-09-22

dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION

#991

20110230542

2011-09-22

Compositions and methods for inhibiting expression of the PCSK9 gene

#992

20110230410

2011-09-22

Low density lipoprotein receptor-mediated siRNA delivery

#993

20110224282

2011-09-15

iRNA agents targeting VEGF

#994

20110224277

2011-09-15

Oligomeric compounds and compositions for use in modulation of small non-coding RNAS

#995

20110218334

2011-09-08

PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND NON-NUCLEOSIDIC PHOSPHOROTHIOATES AS DELIVERY AGENTS FOR iRNA AGENTS

#996

20110207799

2011-08-25

Compositions for targeted delivery of siRNA

#997

20110201798

2011-08-18

Therapeutic compositions

#998

20110184047

2011-07-28

RNAi modulation of SCAP and therapeutic uses thereof

#999

20110184043

2011-07-28

Inhibition of angiogenesis

#1000

20110172291

2011-07-14

RNA interference for the treatment of gain-of-function disorders

#1001

20110171730

2011-07-14

Conjugates For Use In Hepatocyte Free Uptake Assays

#1002

20110152349

2011-06-23

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF IL-18 GENES

#1003

20110124711

2011-05-26

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE

#1004

20110118340

2011-05-19

DELIVERY OF RNAI CONSTRUCTS TO OLIGODENDROCYTES

#1005

20110112178

2011-05-12

Compositions and methods for inhibiting expression of IKK-B gene

#1006

20110112176

2011-05-12

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF KIF10 GENES

#1007

20110104255

2011-05-05

THERAPEUTIC AGENT FOR FIBROID LUNG

#1008

20110097390

2011-04-28

Ultra-small RNAs as toll-like receptor-3 antagonists

#1009

20110071211

2011-03-24

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

#1010

20110071209

2011-03-24

RNAi Modulation of the RHO-A Gene and Uses Thereof

#1011

20110065775

2011-03-17

Compounds and methods for modulating expression of SGLT2

#1012

20110065774

2011-03-17

CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF

#1013

20110054160

2011-03-03

Therapeutic compositions

#1014

20110046206

2011-02-24

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#1015

20110034545

2011-02-10

Double-stranded lipid-modified RNA having high RNA interference effect

#1016

20110034537

2011-02-10

Compositions and methods for inhibiting expression of CD45 gene

#1017

20110034532

2011-02-10

Modulation of T cell signaling threshold and T cell sensitivity to antigens

#1018

20110027882

2011-02-03

Methods and Compositions for Treating Neurological Disease

#1019

20110015252

2011-01-20

Lipid formulated dsRNA targeting the PCSK9 gene

#1020

20110015250

2011-01-20

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 GENE

#1021

20110003882

2011-01-06

RNAi modulation of Aha and therapeutic uses thereof

#1022

20100331234

2010-12-30

Aminoalcohol lipidoids and uses thereof

#1023

20100324120

2010-12-23

Lipid formulation

#1024

20100316707

2010-12-16

Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells

#1025

20100305195

2010-12-02

MICRORNA MEDIATOR OF CARDIOMYOPATHY AND HEART FAILURE

#1026

20100298405

2010-11-25

Compositions and methods for inhibiting expression of Huntingtin gene

#1027

20100292455

2010-11-18

Modified iRNA agents

#1028

20100286234

2010-11-11

Pharmaceutical composition comprising anti-mirna antisense oligonucleotide

#1029

20100285073

2010-11-11

Micro-RNA family that modulates fibrosis and uses thereof

#1030

20100267813

2010-10-21

Method for inhibiting the activity of mir-155

#1031

20100267810

2010-10-21

METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASE

#1032

20100267806

2010-10-21

LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES

#1033

20100249217

2010-09-30

Modulators of pharmacological agents

#1034

20100249215

2010-09-30

Oligomeric compounds and compositions for use in modulation of pri-miRNAs

#1035

20100249052

2010-09-30

DSRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTIONS

#1036

20100240881

2010-09-23

Therapeutic compositions

#1037

20100234282

2010-09-16

System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron

#1038

20100222413

2010-09-02

Chemically modified oligonucleotides for use in modulation micro RNA and uses thereof

#1039

20100216972

2010-08-26

RNAi inhibition of alpha-ENaC expression

#1040

20100216971

2010-08-26

RNAi inhibition of alpha-ENaC expression

#1041

20100216866

2010-08-26

RNAi modulation of APOB and uses thereof

#1042

20100210514

2010-08-19

RNAi inhibition of alpha-ENaC expression

#1043

20100210513

2010-08-19

RNAi inhibition of alpha-ENaC expression

#1044

20100190714

2010-07-29

RNAi inhibition of alpha-ENaC expression

#1045

20100190689

2010-07-29

COMPOSITIONS AND METHODS RELATED TO PROTEIN DISPLACEMENT THERAPY FOR MYOTONIC DISTROPHY

#1046

20100184829

2010-07-22

RNAi modulation of SCAP and therapeutic uses thereof

#1047

20100184823

2010-07-22

dsRNA For Treating Viral Infection

#1048

20100184209

2010-07-22

COMPOSITIONS AND METHODS FOR INHIBITING GENE SILENCING BY RNA INTERFERENCE

#1049

20100183704

2010-07-22

dsRNA FOR TREATING VIRAL INFECTION

#1050

20100179309

2010-07-15

Modified iRNA agents

#1051

20100173359

2010-07-08

Enhanced biotherapeutic production using inhibitory RNA

#1052

20100168206

2010-07-01

GNAQ targeted dsRNA compositions and methods for inhibiting expression

#1053

20100160617

2010-06-24

Nuclease-resistant RNA aptamer inhibiting replication of hepatitis C virus replicon

#1054

20100144846

2010-06-10

Oligoribonucleotides and uses thereof

#1055

20100120893

2010-05-13

Compositions and methods for inhibiting expression of transthyretin

#1056

20100113562

2010-05-06

Therapeutic targets and molecules

#1057

20100093085

2010-04-15

Tripartite oligonucleotide complexes and methods for gene silencing by RNA interference

#1058

20100087508

2010-04-08

Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes

#1059

20100077085

2010-03-25

Systems and method for configuring display resolution in a terminal server environment

#1060

20100069471

2010-03-18

Chemically modified oligonucleotides

#1061

20100035976

2010-02-11

Method of treating a cancer by administering A 2′,5′-oligoadenylate analog

#1062

20100029922

2010-02-04

Platelet derived growth factor (PDGF) nucleic acid ligand complexes

#1063

20100016407

2010-01-21

Combined telomerase inhibitor and gemcitabine for the treatment of cancer

#1064

20100010066

2010-01-14

Optimized Methods For Delivery Of DSRNA Targeting The PCSK9 Gene

#1065

20100010064

2010-01-14

Cancer treatment by combined inhibition of proteasome and telomerase activities

#1066

20100004432

2010-01-07

Aptamer against midkine and use thereof

#1067

20100004320

2010-01-07

Pharmaceutical Composition

#1068

20090326042

2009-12-31

COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF CRP

#1069

20090326041

2009-12-31

COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF SGLT2

#1070

20090324584

2009-12-31

Nucleic Acid of Formula (I): GIXmGn, or (II): CIXmCn, in Particular as an Immune-Stimulating Agent/Adjuvant

#1071

20090318532

2009-12-24

Compounds and methods for modulating expression of PTP1B

#1072

20090317907

2009-12-24

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#1073

20090312397

2009-12-17

RNAi modulation of ApoB and uses thereof

#1074

20090306357

2009-12-10

Compounds and methods for modulating expression of GCCR

#1075

20090306180

2009-12-10

Compounds and methods for modulating expression ApoB

#1076

20090306179

2009-12-10

Compounds and methods for modulating expression of GCGR

#1077

20090306178

2009-12-10

CONJUGATED DOUBLE STRAND COMPOSITIONS FOR USE IN GENE MODULATION

#1078

20090306005

2009-12-10

Compounds and methods for modulating expression of PCSK9

#1079

20090298174

2009-12-03

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#1080

20090292006

2009-11-26

COMPOUNDS AND METHODS FOR MODULATING EXPRESSION OF DGAT2

#1081

20090291907

2009-11-26

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#1082

20090291906

2009-11-26

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#1083

20090286973

2009-11-19

Ligand-conjugated monomers

#1084

20090286969

2009-11-19

Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs

#1085

20090286853

2009-11-19

MODIFIED OLIGONUCLEOTIDES FOR TELOMERASE INHIBITION

#1086

20090286851

2009-11-19

Compositions and methods for delivering RNAI using lipoproteins

#1087

20090281164

2009-11-12

RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)

#1088

20090264511

2009-10-22

Compositions and methods for inhibiting expression of factor VII gene

#1089

20090258934

2009-10-15

Compositions and methods for inhibiting expression of Nav1.8 gene

#1090

20090258424

2009-10-15

Cellular Delivery of siRNA

#1091

20090247607

2009-10-01

dsRNA compositions and methods for treating HPV infection

#1092

20090239931

2009-09-24

RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

#1093

20090209626

2009-08-20

Duplex oligonucleotides with enhanced functionality in gene regulation

#1094

20090208468

2009-08-20

Suppressors of CpG oligonucleotides and methods of use

#1095

20090202493

2009-08-13

MIR-150 FOR THE TREATMENT OF BLOOD DISORDERS

#1096

20090186410

2009-07-23

RNA SILENCING COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUNTINGTON'S DISEASE

#1097

20090182136

2009-07-16

Small internally segmented interfering RNA

#1098

20090156541

2009-06-18

DBAIT and uses thereof

#1099

20090156529

2009-06-18

RNAi inhibition of alpha-ENaC expression

#1100

20090149403

2009-06-11

SiRNA silencing of genes expressed in cancer

#1101

20090131358

2009-05-21

LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY

#1102

20090118213

2009-05-07

RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF APO-B100 EXPRESSION

#1103

20090105174

2009-04-23

NUCLEIC ACIDS HYBRIDIZABLE TO MICRO RNA AND PRECURSORS THEREOF

#1104

20090093426

2009-04-09

RNAi modulation of SCAP and therapeutics uses thereof

#1105

20090062226

2009-03-05

Method and compositions for inhibiting MAGE protein interaction with KAP-1

#1106

20090023675

2009-01-22

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

#1107

20080269148

2008-10-30

Modified small interfering RNA molecules and methods of use

#1108

20080261304

2008-10-23

METHODS AND COMPOSITIONS FOR ENHANCING DELIVERY OF DOUBLE-STRANDED RNA OR A DOUBLE-STRANDED HYBRID NUCLEIC ACID TO REGULATE GENE EXPRESSION IN MAMMALIAN CELLS

#1109

20080221055

2008-09-11

Compositions and methods for inhibiting expression of Huntingtin gene

#1110

20080207883

2008-08-28

Platelet derived growth factor (PDGF) nucleic acid ligand complexes

#1111

20080200416

2008-08-21

Modulation of T cell signaling threshold and T cell sensitivity to antigens

#1112

20080199960

2008-08-21

Methods for the Delivery of Oligomeric Compounds

#1113

20080188429

2008-08-07

Synthetic siRNA compounds and methods for the downregulation of gene expression

#1114

20080113931

2008-05-15

RNAi modulation of Aha and therapeutic uses thereof

#1115

20080113930

2008-05-15

Compositions and methods for inhibiting expression of the PCSK9 gene

#1116

20080108801

2008-05-08

Lipophilic conjugated iRNA agents

#1117

20080108584

2008-05-08

Compositions and methods for inhibiting expression of IKK-B gene

#1118

20080085869

2008-04-10

Duplex oligonucleotide complexes and methods for gene silencing by RNA interference

#1119

20080051339

2008-02-28

Modulators of pharmacological agents

#1120

20080039415

2008-02-14

RETROGRADE TRANSPORT OF SIRNA AND THERAPEUTIC USES TO TREAT NEUROLOGIC DISORDERS

#1121

20080015162

2008-01-17

Short antisense compounds with gapmer configuration

#1122

20070299022

2007-12-27

Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA

#1123

20070281900

2007-12-06

COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY

#1124

20070281899

2007-12-06

Compositions and methods for inhibiting expression of Eg5 gene

#1125

20070275919

2007-11-29

RNA amidates and thioamidates for RNAi

#1126

20070275914

2007-11-29

Therapeutic compositions

#1127

20070213292

2007-09-13

Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof

#1128

20070179100

2007-08-02

Protected monomers

#1129

20070161591

2007-07-12

Methods and compositions for treating neurological disease

#1130

20070123482

2007-05-31

Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof

#1131

20070111961

2007-05-17

Dbait and uses thereof

#1132

20070105806

2007-05-10

Compositions and methods for inhibiting expression of Nav1.8 gene

#1133

20070105803

2007-05-10

Methods and compositions for treating neurological disease

#1134

20070099860

2007-05-03

Compositions and methods for inhibiting expression of Huntingtin gene

#1135

20070044161

2007-02-22

RNAi modulation of the Rho-A gene in research models

#1136

20070042984

2007-02-22

iRNA agents targeted to the Rho-A gene

#1137

20070032441

2007-02-08

Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)

#1138

20070021327

2007-01-25

Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor

#1139

20060252722

2006-11-09

Oligomeric compounds and compositions for use in modulation of pri-mirnas

#1140

20060246123

2006-11-02

Oligonucleotide mimetics

#1141

20060241076

2006-10-26

Modified oligoribonucleotide analogs with enhanced immunostimulatory activity

#1142

20060223770

2006-10-05

IRNA agents targeting VEGF

#1143

20060217324

2006-09-28

RNAi modulation of the Nogo-L or Nogo-R gene and uses thereof

#1144

20060178324

2006-08-10

Lipophilic derivatives of double-stranded ribonucleic acid

#1145

20060105976

2006-05-18

RNAi modulation of ApoB and uses thereof

#1146

20060094032

2006-05-04

iRNA agents targeting VEGF

#1147

20060084094

2006-04-20

Conjugates for use in hepatocyte free uptake assays

#1148

20060058266

2006-03-16

Chemically modified oligonucleotides

#1149

20060051405

2006-03-09

Compositions for the delivery of therapeutic agents and uses thereof

#1150

20060025361

2006-02-02

RNA interference mediated inhibition of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

#1151

20060019913

2006-01-26

RNA interference mediated inhibtion of protein tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

#1152

20060014289

2006-01-19

Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells

#1153

20050288244

2005-12-29

Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine

#1154

20050261235

2005-11-24

2′, 5′-oligoadenylate analogs

#1155

20050261218

2005-11-24

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#1156

20050233342

2005-10-20

Methods of preventing off-target gene silencing

#1157

20050176667

2005-08-11

Compositions and methods for inhibiting expression of anti-apoptotic genes

#1158

20050164235

2005-07-28

Modified iRNA agents

#1159

20050119470

2005-06-02

Conjugated oligomeric compounds and their use in gene modulation

#1160

20050119214

2005-06-02

Nuclease resistant double-stranded ribonucleic acid

#1161

20050113325

2005-05-26

Modified oligonucleotides for telomerase inhibition

#1162

20050107325

2005-05-19

Modified iRNA agents

#1163

20050106598

2005-05-19

Novel peptide-conjugated oligomeric compounds

#1164

20050058982

2005-03-17

Modified small interfering RNA molecules and methods of use

#1165

20050042273

2005-02-24

Platelet derived growth factor (PDGF) nucleic acid ligand complexes

#1166

20050019761

2005-01-27

Oligonucleotides, agents containing these oligonucleotides, and the use thereof

#1167

17364754

2022-06-21

Nucleic acid-polypeptide compositions and uses thereof

#1168

17321561

2021-12-28

Coronavirus iRNA compositions and methods of use thereof

#1169

17070287

2022-04-12

Conjugated antisense compounds and their use

#1170

16354916

2020-01-07

Double-stranded ribonucleic acid capable of suppressing expression of complement C5

#1171

15250175

2018-01-16

Methods and formulations for topical treatment of psoriasis

#1172

13254770

2015-07-28

Nucleic acid complex and nucleic acid-delivering composition